After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32376171.
- Also identified by DOI 10.1016/j.arth.2020.04.040 and PMC identifier 7195118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The novel coronavirus, severe acute respiratory coronavirus 2 (SARS-CoV-2), pandemic has delivered a profound and negative impact on the United States. The suspension of elective surgeries including arthroplasty will have a lasting effect on all stakeholders including patients, physicians, and healthcare organizations within the US healthcare system. Resumption of elective hip and knee arthroplasty will need to be carefully focused. The purpose of this work is to address potential strategies, concerns, and regulatory barriers in restarting elective hip and knee arthroplasty in the United States.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral